Artificial Intelligence
Clinical Trials Matching Software Market Size to Observe Highest Growth of USD 326.23 million with an Excellent CAGR of 13.50% by The End of 2028
Chicago, Jan. 17, 2023 (GLOBE NEWSWIRE) — Markets N Research has recently released expansive research on Global Clinical Trials Matching Software Market with 100+ market data Tables, Pie Chart, and Graphs & Figures spread through Pages and easy to understand detailed analysis. The report endows with wide-ranging statistical analysis of the market’s continuous developments, capacity, production, production value, cost/profit, supply/demand and import/export. This market report provides best solutions for strategy development and implementation depending on client’s needs to extract tangible results. This market research report serves the clients by providing data and information on their business scenario with which they can stay ahead of the competition in today’s rapidly changing business environment.
As per the report titled “Clinical Trials Matching Software Market Size, Share & COVID-19 Impact Analysis, By Component (Services and Software), By End User (Clinical Research Organizations (CRO), Pharmaceutical and biotechnology Companies and Medical Device Firms), By Deployment Mode (On-Premise and Web and Cloud-based) and Regional Forecasts, 2022-2028″ observes that the market size in 2021 stood at USD 152.6 million and USD 326.23 million in 2028. The market is expected to exhibit a CAGR of 13.50% during the forecast period.
Get a Sample PDF of Clinical Trials Matching Software Market Research Report: https://marketsnresearch.com/sample/1597
Clinical Trials Matching Software Market Analysis:
The prevalence of chronic illnesses and the growing demand for clinical trials are predicted to fuel the market for clinical trial matching software during the anticipated time frame. Market participants are focusing more on new features and creating innovative products due to supportive government initiatives and swiftly advancing technology. Additionally, the healthcare industry is also growing as a result of the quick rise in the number of businesses offering novel customizable features. Clinical trial software is predicted to grow in importance in the future, driving the global market for clinical trial matching software throughout the forecast period due to the increasing demand for remote monitoring services and digitally connected platforms.
Report Scope:
| Report Coverage | Details |
| Forecast Period | 2023-2030 |
| Forecast Period 2023 to 2030 CAGR | 13.50 % |
| 2028 Value Projection | 326.23 million |
| Base Year | 2022 |
| Market Size in 2021 | 152.6 million |
| Historical Data for | 2016 – 2021 |
| Segments covered | By Components, By End-User, By Deployment Mode and By Geography |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
List Of Key Companies Profiled:
- Advarra
- Antidote Technologies, Inc.
- IBM Clinical Development
- Clinical Trials Mobile Application
- SSS International Clinical Research
- Aris Global
- Clario
- Bsi Business Systems Integration AG
- Microsoft Corporation
- Ofni Systems
ERT Merged with Bioclinica to Combine Imaging, eClinical Software, and Drug Safety Expertise
In April 2021, Clario, a market leader in clinical endpoint data solutions, was the new name of the firm created by the union of ERT and Bioclinica. Through this merger, ERT and Bioclinica combined their respective strengths in wearable technology, cardiac safety, eClinical software, and drug safety solutions. The development objective was to integrate the two companies’ technological advantages in order to offer a better service to a bigger customer base.
Major Players Develop Acquisition Plans to Boost Brand Image
The leading businesses in the clinical trials matching software market plan acquisitions to improve their brand recognition globally. For instance, in March 2021, according to Advarra, the purchase of Bio-Optronics, maker of CCTrialSuite and a supplier of clinical trial management system (CTMS) solutions for the healthcare sector and clinical research, has been finished. This business offers technologies to improve clinical trials’ safety, intelligence, and speed. This purchase strategy allowed the business to increase the range of its products and consumer base.
Make an Enquiry before Buying @ https://marketsnresearch.com/buying-request/1597
Our Free Sample Report Consists of the following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
- The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
- About 220+ Pages Research Report (Including Recent Research)
- Provide detailed chapter-by-chapter guidance on the Request
- Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2022
- Includes Tables and figures have been updated
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
- MNR research methodology
Driving Factors:
- Growing Clinical Trial Activity is Anticipated to Fuel Market Expansion
It is anticipated that rising clinical trial activity will fuel the market for clinical trials matching software. Over the past few decades, there had been a tremendous increase in clinical studies. This is a result of the increased penetration of cutting-edge medical technology and the rising desire for novel medications with higher efficacy. But because clinical trials are designed to gather and organize data that can be shared with several healthcare practitioners and disseminated across multiple systems, a clinical trial matching system is quick and inexpensive. The monitoring and tracing of patient registrations and databases, as well as location identification and recruitment, can all be aided by this technology.
- Government Initiatives and Company Collaborations to Boost Market Growth
The supportive government initiatives and various company partnerships for the Clinical trial matching software market will likely drive new participant entry in the future, driven by awareness and adoption of an increasing number of trial activities and technology processes. Rapid technological advancement encourages market participants to focus on new applications and developing innovative devices. Furthermore, the growing number of companies offering updated and customized features fuel market growth during the forecast period.
Restraining Factors:
- Market’s Expansion is Being Hampered by the High Cost of Matching Software
The high cost of matching systems is constraining the market expansion of clinical trial matching software. Initialization, contractual term commitment, per user, per study, training, support and maintenance, validation/21 part 11 compliance, and system integration fees collectively increase the entire cost necessary for clinical trial matching software solutions deployment. Setup fees apply to both on-premises and SaaS solutions. Companies are assessed additional configuration and modification fees following their unique organizational and research needs. Different cost structures are seen depending on the number of users and sites taken into consideration.
To Gain More Insights into the Market Analysis, Browse Summary of the Clinical Trials Matching Software Market Report @ https://marketsnresearch.com/report/1597/global-clinical-trials-matching-software-market
Global Clinical Trials Matching Software Market Segmentations:
Global Clinical Trials Matching Software Market By Components:
- Services
- Software
Global Clinical Trials Matching Software Market By End-User:
- Clinical Research Organizations (CRO)
- Pharmaceutical and biotechnology Companies
- Medical Device Firms
Global Clinical Trials Matching Software Market By Deployment Mode:
- On-Premise
- Web and Cloud based
Global Clinical Trials Matching Software Market Regional Insights:
North America is projected to hold the largest clinical trials matching software market share over the forecast period. The introduction of drug trial matching systems by American pharmaceutical and biotechnology businesses is credited with the growth. Additionally, the encouraging government IT initiatives and the growing use of patient matching and clinical trial matching software are contributing to the expansion of this industry.
Further Report Findings
- The market in North America is expected to gain a huge portion of the global clinical trials matching software market share in the coming years because pharmaceutical and biotechnology businesses in the U.S. are increasingly adopting clinical trial matching software.
- Additionally, the region’s market is growing due to favorable government initiatives for IT and AI-based solutions, increased adoption of CTMS, and patient matching software.
- In Asia Pacific, the growth in this region is primarily driven by the region’s huge patient pool’s accessibility, making patient recruitment processes simpler.
Access Full Report @ https://marketsnresearch.com/checkout/1597/1ecda5z5e4
Key questions answered in this report:
- What is the size of the Clinical Trials Matching Software market and what is its expected growth rate?
- What are the primary driving factors that push the Clinical Trials Matching Software market forward?
- What are the Clinical Trials Matching Software Industry’s top companies?
- What are the different categories that the Clinical Trials Matching Software Market caters to?
- What will be the fastest-growing segment or region?
- In the value chain, what role do essential players play?
- What is the procedure for getting a free copy of the Clinical Trials Matching Software market sample report and company profiles?
Key Offerings:
- Market Share, Size & Forecast by Revenue | 2023−2030
- Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends
- Market Segmentation – A detailed analysis By Components, By End-User, By Deployment Mode and By Geography
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Table of Content
Chapter 1: Preface
Chapter 2: Report Summary
Chapter 3: COVID 19 Impact Analysis
Chapter 4: Global Clinical Trials Matching Software Market, By Components Segment Analysis
Chapter 5: Global Clinical Trials Matching Software Market, By End-User Segment Analysis
Chapter 6: Global Clinical Trials Matching Software Market, By Deployment Mode Segment Analysis
Chapter 7: Clinical Trials Matching Software Market – Regional Analysis, 2022 – 2030
Chapter 8: Clinical Trials Matching Software Market – Industry Analysis
Chapter 9: Competitive Landscape
Chapter 10: Company Profiles
Chapter 11: Research Methodology
Chapter 12: Questionnaire
Chapter 13: Related Reports
Customize this Report @ https://marketsnresearch.com/customization-request/1597
Key Insights from Primary Research/Key Insights & Findings from the report:
- As per the analysis shared by our primary respondents, the Clinical Trials Matching Software market is expected to grow annually at a CAGR of around 13.50%.
- Through primary research, it was established that the Clinical Trials Matching Software market was valued at around USD 152.6 million in 2021.
- The Clinical Trials Matching Software market is segmented based on components: services and software. The software was predicted to show maximum market share in the year 2021.
- The “North America” region will lead the global Clinical Trials Matching Software market during the forecast period 2022 to 2030.
Spectacular Deals
- Comprehensive coverage
- Maximum number of market tables and figures
- Subscription-based option offered
- Best price guarantee
- Free 35% or 60 hours of customization.
- Free post-sale service assistance.
- 25% discount on your next purchase.
- Service guarantees are available.
- Personalized market brief by author.
Read More Info @ https://www.linkedin.com/pulse/clinical-trials-matching-software-market-2023-size-share-smith/
Browse More Markets N Research Reports:
Global Smart Wearable Bands Market Size, Share & COVID-19 Impact Analysis, By Product Type (With Screen and Without Screen), By Operating System (Android, Windows, iOS and Others), By Distribution Channel (Specialist Retailers, Company Outlets, Online and Others) and Regional Forecasts, 2023-2030: https://marketsnresearch.com/report/1602/global-smart-wearable-bands-market
Global SMS Firewall Market Size, Share & COVID-19 Impact Analysis, By Components (Platforms and Services), By Services (Professional Services and Managed Services), By SMS Type (Application-to-Person (A2P) Messages and Person-to-Application (P2A) Messages), By SMS Traffic (National SMS Traffic and International SMS Traffic), By Deployment Modes (On-premises and Cloud), and Regional Forecasts, 2023-2030: https://marketsnresearch.com/report/1605/global-sms-firewall-market
Global Soy Protein Market Size, Share & COVID-19 Impact Analysis, By Type (Soy Protein Concentrates, Soy Protein Isolates, Textured Soy Proteins and Other Types (Soy Flour, Grits, & Chunks)), By Crop Type (Genetically Modified Organism Crops and Non-Genetically Modified Organism Crops), By Source Process (Conventional Soy Protein Ingredients and Organic Soy Protein Ingredients), By Form (Solid/Dry and Liquid), By Application (Food & Beverages (Meat, Poultry, and Seafood, Bakery & Confectionery, Meat Analogues, Dairy & Dairy Alternatives, Beverages, Other Food & Beverage Applications) Animal Feed, Nutrition & Health Supplements and Other Applications) and Regional Forecasts, 2023-2030: https://marketsnresearch.com/report/1611/global-soy-protein-market
Global Alcoholic Beverages Market Size, Share & COVID-19 Impact Analysis, By Type (Beer, Distilled Spirits, Wine, and Others), By Distribution Channel (Convenience Stores, On-Premises, Liquor Stores, Grocery Shops, Internet Retailing, and Supermarkets) and Regional Forecasts, 2022-2028: https://marketsnresearch.com/report/1593/global-alcoholic-beverages-market
Global Smart Manufacturing Market Size, Share & COVID-19 Impact Analysis, By Information Technology (Human-machine Interface, Plant asset management, Manufacturing execution system and Warehouse management system Dual Frequency), By Enabling Technology (Industrial 3D Printing, A.I. in Manufacturing, Industrial Cybersecurity, Industrial Machine Vision,, Industrial Sensors, Digital Twins, Robots,, Automoted Guided Vehicles, Machine Condition Monitoring, Artificial Reality & Virtual Reality and 5G Industrial IoT), By Industry (Process Industry, Oil & Gas, Food & Beverages, Pharmaceuticals, Chemicals, Energy & Power, Metals & Mining, Pulp & Paper, Others), Discrete Industry (Automotive, Aerospace & Defense, Semiconductor &, Electronics, Medical Devices, Machine, Manufacturing, Others), Mining, Construction, Oil & Gas and Others) and Regional Forecasts, 2022-2028: https://marketsnresearch.com/report/1594/global-smart-manufacturing-market
Global Financial Analytics Market Size, Share & COVID-19 Impact Analysis, By Component (Solution and Services), By Deployment mode (On-Premise and Cloud), By Organization Size (Large Enterprises and Small & Medium Sized Enterprises), By Industrial Vertical (BFSI, IT and Telecom, Manufacturing, Retail and E-commerce, Government, Healthcare and Others) and Regional Forecasts, 2022-2028: https://marketsnresearch.com/report/1595/global-financial-analytics-market
About Markets N research
When it comes to investing and money matters, you need the leading market research consultancy firm to help you make the right decisions during the toughest business questions and decisions. Markets N Research is the leading research company offering both tactical and strategic support to all our customers. Customer satisfaction is our goal and that is why, we have a team of skilled and experienced specialist with the ability to do data mining, information management, and revenue enhancement solutions to ensure that our clients make informed decisions when coming to investing in the market.
Markets N Research team is comprised of well skilled and equipped personnel ready to concur any upcoming challenges in the market sector for both individual people and organization around the world. We know time is money, and therefore we ensure we solve your problem within the shortest time possible to prevent delays or missing any opportunities. We use globally accepted techniques with a little innovation from our staff in solving all your market research related challenges.
Contact Us:
Markets N Research
US: +1-773-649-1529
Email:- [email protected]
Website: https://marketsnresearch.com/
Follow on Linkedin: https://www.linkedin.com/company/markets-n-research
Follow on Twitter: https://twitter.com/marketsnr
Like us on Facebook: https://www.facebook.com/Markets-N-Research-108839598639025
Artificial Intelligence
Clinical Trials Matching Software Market Projected to Reach $832.56 million by 2030 – Exclusive Report by 360iResearch
PUNE, India, April 18, 2024 /PRNewswire/ — The report titled “Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use – Global Forecast 2024-2030” is now available on 360iResearch.com’s offering, presents an analysis indicating that the market projected to grow from a size of $342.20 million in 2023 to reach $832.56 million by 2030, at a CAGR of 13.54% over the forecast period.
“The Global Surge in Adoption of Matching Software for Enhanced Participant Enrollment”
Clinical trials matching software stands at the forefront of revolutionizing clinical research by automating the process of identifying and enrolling eligible participants. These platforms offer a streamlined approach to match patient health profiles with trial requirements, accelerating enrollment and supporting the shift toward personalized healthcare using these advanced AI and ML technologies. Although integrating these systems poses challenges due to variations in healthcare IT infrastructure and the imperative for rigorous data security, the potential for market growth is substantial. In the Americas, a robust clinical trials ecosystem thrives; in the European Union, it has unified regulatory standards and extended to emerging regions such as the Middle East, Africa, and the APAC countries; the demand for such innovative solutions is on a steep rise. This demand is fueled by governmental support, the evolving regulatory landscape, and strategic partnerships to embed these solutions within electronic health records, underscoring a global movement toward optimizing clinical trial processes to better cater to specific patient demographics.
Download Sample Report @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“The Rise of Virtual Trials and Advanced Matching Software”
The healthcare landscape is witnessing a transformative shift toward virtual clinical trials, fueled by technological advancements and the necessity for continuity during the COVID-19 pandemic. This transition supports research amid social distancing measures and introduces significant cost savings by reducing the need for physical infrastructure and in-person interactions. The efficiencies brought by electronic health records (EHR), wearable technologies, and automation streamline the entire process, from patient recruitment to data analysis. Several approaches, endorsed by regulatory bodies such as the FDA, represent a leap forward in making clinical trials more accessible and streamlined, ensuring that more patients can participate in potentially life-saving research without the geographical and logistic constraints of traditional trials.
“Enhancing Clinical Trials through Advanced Analytics, Rigorous Compliance, and Precision-Patient Matching”
Integrating advanced analytics, meticulous compliance monitoring, and precision-patient matching marks a significant advancement toward maximizing efficiency and fostering trial diversity. The software delivers insightful data on trial progress, participant demographics, and enrollment figures, empowering stakeholders to make well-informed decisions and optimize resource distribution to meet trial goals effectively by implementing cutting-edge analytics. The built-in compliance feature ensures trials are conducted in strict adherence to regulatory standards, minimizing risks associated with non-compliance. Furthermore, a robust data management system guarantees the integrity and availability of clinical trial data, which is critical for the seamless operation and real-time analysis of trials. The software includes state-of-the-art patient matching technology, which employs sophisticated algorithms and artificial intelligence to expedite recruitment by accurately identifying candidates who match specific trial requirements. This innovative approach accelerates the recruitment timeline and enhances the diversification of trial participants, paving the way for more inclusive and representative clinical research outcomes.
Request Analyst Support @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Medidata by Dassault Systèmes SE at the Forefront of Clinical Trials Matching Software Market with a Strong 11.30% Market Share”
The key players in the Clinical Trials Matching Software Market include International Business Machines Corporation, Science 37, Inc. by eMed, LLC, Medidata by Dassault Systèmes SE, AutoCruitment LLC, Deep 6 AI Inc., and others. These prominent players focus on strategies such as expansions, acquisitions, joint ventures, and developing new products to strengthen their market positions.
“Introducing ThinkMi: Revolutionizing Market Intelligence with AI-Powered Insights for the Clinical Trials Matching Software Market”
We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Clinical Trials Matching Software Market. ThinkMi stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it’s a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Clinical Trials Matching Software Market. Embrace the future of market analysis with ThinkMi, where informed decisions lead to remarkable growth.
Ask Question to ThinkMi @ https://app.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Dive into the Clinical Trials Matching Software Market Landscape: Explore 190 Pages of Insights, 286 Tables, and 22 Figures”
PrefaceResearch MethodologyExecutive SummaryMarket OverviewMarket InsightsClinical Trials Matching Software Market, by FunctionalityClinical Trials Matching Software Market, by DeploymentClinical Trials Matching Software Market, by End-UseAmericas Clinical Trials Matching Software MarketAsia-Pacific Clinical Trials Matching Software MarketEurope, Middle East & Africa Clinical Trials Matching Software MarketCompetitive LandscapeCompetitive PortfolioInquire Before Buying @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
Related Reports:
Clinical Trial Support Services Market – Global Forecast 2024-2030Virtual Clinical Trials Market – Global Forecast 2024-2030Clinical Trials Management System Market – Global Forecast 2024-2030About 360iResearch
Founded in 2017, 360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset — our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
Contact 360iResearchMr. Ketan Rohom360iResearch Private Limited,Office No. 519, Nyati Empress,Opposite Phoenix Market City,Vimannagar, Pune, Maharashtra,India – 411014.Email: [email protected]: +1-530-264-8485India: +91-922-607-7550
To learn more, visit 360iresearch.com or follow us on LinkedIn, Twitter, and Facebook.
Logo – https://mma.prnewswire.com/media/2359256/360iResearch_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/clinical-trials-matching-software-market-projected-to-reach-832-56-million-by-2030—exclusive-report-by-360iresearch-302119709.html
BOSTON, April 18, 2024 /PRNewswire/ — The RepTrak™ Company, the world’s leading reputation data and insights company, released its annual Global RepTrak 100 report. Utilizing its advanced reputation monitoring software, RepTrak gathered data from more than 243,000 survey responses across 14 major economies to rank the world’s 100 most reputable companies. They share that ranking alongside a full analysis of global corporate reputation trends and corresponding public sentiment in the 2024 report.
After two years of consecutive Reputation Score declines, this year’s Score is back up with an increase from 73.2 in 2023 to 73.8 in 2024. It’s a small increase after 2023’s full one-point drop. However, it’s an encouraging sign that companies have begun to recover from reputation falls driven by many challenges: macroeconomic issues, workplace difficulties, product problems, and corporate responsibility skepticism.
“This year’s report underscores a pivotal shift in the corporate landscape, spotlighting the remarkable adaptability and dedication of the Top 100 companies in responding to the dynamic needs of stakeholders,” states RepTrak CEO Mark Sonders. “The companies featured in our report are not just riding the wave of change; they are the ones steering it, proving that the best approach to business is one that embraces evolution and champions progress.”
RepTrak’s report explores how people thought, felt, and acted toward companies over the past year. Findings include notable increases in Conduct and Citizenship efforts, stakeholders’ rising willingness to invest, culturally resonant brand communications, and ESG Scores that soared despite skepticism around the acronym.
To read the full 2024 Global RepTrak 100 report, please visit: www.reptrak.com/globalreptrak
About RepTrak
The RepTrak™ Company is the world’s leading reputation data and insights company. We help companies by organizing and grading a variety of reputational elements, offering a real-world report card on their corporate reputation. Subscribers to the RepTrak program use our predictive insights to protect business value, improve return on investment, and increase their positive impact on society. RepTrak’s pairing of advanced metrics and dedicated reputation advisors offers clients an actionable analysis of their reputation data, aligning business objectives with stakeholder sentiment across different markets and sectors.
Established in 2004, The RepTrak Company owns the world’s largest reputation benchmarking database, gathering over 1 million company ratings per year used by CEOs, boards, and executives in more than 60 countries worldwide. For more information, please visit: www.reptrak.com
Logo – https://mma.prnewswire.com/media/2391550/RepTrak_Logo_Logo.jpg
Photo – https://mma.prnewswire.com/media/2391551/2024_GRT_Spreads__Instagram_Post.jpg
View original content:https://www.prnewswire.co.uk/news-releases/reptrak-announces-2024-global-reptrak-100-report-302121513.html
Artificial Intelligence
Group-IB takes part in a global operation to cripple Canadian Phishing-as-a-Service provider LabHost
SINGAPORE, April 18, 2024 /PRNewswire/ — Group-IB, a leading cybersecurity company aimed at investigating, preventing, and fight digital crime announced today that it participated in a coordinated global takedown operation against prominent Canadian Phishing-as-a-Service (PhaaS) provider LabHost, which has led to the arrest of 37 suspects across the United Kingdom and around the world by law enforcement agencies. As part of the operation, Group-IB also conducted an extensive analysis of LabHost’s criminal history and infrastructure, including insights into LabHost’s administrative platform and the services it provides to its purported user base which exceeds 2,000 subscribers worldwide, who illegally obtained around 480,000 card numbers, 64,000 pin numbers, and over 1 million passwords from victims used for websites and other online services, according to law enforcement agencies.
“By leveraging our Threat Intelligence and Digital Risk Protection, we are able to identify and monitor phishing attacks and websites like those deployed by LabHost and its subscribers around the world, enabling us to actively alert and protect our customers, and in turn, their customers as well,” said Dmitry Volkov, Chief Executive Officer of Group-IB. “Today’s takedown operation demonstrates the agility and responsiveness of our decentralized Digital Crime Resistance Centers, and how quickly we can provide immediate and local assistance wherever our customers may be.”
First uncovered in late 2021, LabHost emerged as a fully automated Phishing-as-a-Service (PhaaS) platform, streamlining the creation of phishing websites meticulously mirroring the interface and functionality of prominent banking, postal, and financial entities, aimed at intercepting, seizing, and profiting from users’ personal, credit card, and online banking credentials. Users are prompted to select from various “membership plans,” tailored to target businesses and individuals in either the United States and Canada, or globally, akin to mobile subscription models. These plans encompass “standard,” “premium,” and “world membership” tiers, priced between US$179 and US$300 monthly, with options for monthly, quarterly, or annual billing cycles.
For media inquiries, please contact [email protected]
Photo – https://mma.prnewswire.com/media/2391017/Group_IB.jpgPhoto – https://mma.prnewswire.com/media/2391018/Group_IB_2.jpgLogo – https://mma.prnewswire.com/media/1853638/4657466/Group_IB_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/group-ib-takes-part-in-a-global-operation-to-cripple-canadian-phishing-as-a-service-provider-labhost-302121388.html
-
Artificial Intelligence7 days agoIn-Depth Analysis of Germany and France Data Center Markets: Germany Poised to Contribute Over $12.24 Billion Opportunities in the Next 6 Years – Arizton
-
Artificial Intelligence7 days agoCogX Festival Set to Debut in Los Angeles at Century Plaza on May 7th, 2024
-
Artificial Intelligence7 days ago
aelf Leads the Fusion of AI and Blockchain to Shape the Future of Technology
-
Artificial Intelligence7 days agoXinhua Silk Road: Zoomlion Access pursues high-quality development with aerial work machinery sector innovation
-
Uncategorized7 days agoDFI’s Latest Compact Industrial Computer Equipped with AI Acceleration Module
-
Uncategorized7 days ago
DFI Amplifies AI Capability for the Thriving EV Market and Beyond
-
Artificial Intelligence4 days agoSilent Eight secures AIA as its latest client
-
Artificial Intelligence4 days agoGlobal Networking Innovator Huawei Leads the New Era of Campus Network Technology
